Telangana Unveils Life Sciences Policy to Boost Investments

Quick Summary

• Telangana’s Industries and IT Minister, D. Sridhar babu, announced plans to unveil a next-generation Life Sciences policy aimed at attracting large-scale investments.
• The state targets scaling its life sciences economy from the current $80 billion to $250 billion by 2030 and aspires to become Asia’s life sciences capital.
• Telangana is home to over 2,000 life sciences companies and more than 250 U.S. FDA-approved sites, making it a major hub in the sector.
• Since december 2023,Hyderabad has attracted ₹54,000 crore in global investments across pharmaceuticals,biotechnology,cell and gene therapy,medical devices,vaccines,and digital health.
• Hyderabad ranks among the top seven global life sciences clusters and is noted as the only Indian city on this list. Companies like Eli Lilly and Amgen have chosen Hyderabad as their operational hubs.
• The sector’s growth promises potential employment generation of over two lakh jobs in areas such as biosimilars production, AI/ML technologies for healthcare services, biologics manufacturing, etc.
• Plans are underway for feasibility studies regarding establishing the Telangana School of Life Sciences to further educational infrastructure in this domain.

indian Opinion Analysis

The strategic vision outlined by telangana reflects its ambitions of redefining India’s place globally within the high-value life sciences market while consolidating Hyderabad’s position among elite industry clusters worldwide. The ₹54,000 crore investments signal strong investor confidence bolstered by robust policy measures like industry-amiable incentives paired with forward-looking infrastructure development.

Telangana’s focus on multi-disciplinary areas such as AI/ML applications alongside traditional domains ensures that its growth trajectory aligns with emerging trends reshaping healthcare delivery systems globally. However-as with scaling ecosystems-ensuring equitable job creation beyond metros balanced reflecting regional workforce-opportunity else populations risk exploitation at cost innovation نمایой